Health CanadaType II
JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification i...
Published: June 25, 2024Recall ID: 75738Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
JAMP-Doxazosin 4 mg
Additional Source Details
| Field | Value |
|---|---|
| N I D | 75738 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/jamp-doxazosin-4-mg-uniformity-dosage-unit-may-be-out-specification-affected-lot |
| Issue | Product quality |
| Title | JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot. |
| Product | JAMP-Doxazosin 4 mg |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2024-06-25 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |